Dr Lipton publishes the first article with a treatment for MEF2C Syndrome
November 14 has been one of the most special days so far, for those of us who are part of this Association as well as for all children suffering from MEF2C Syndrome and their families.
Dr. Lipton has published the first article about the drug tested in mice to treat the illness of our little ones. The drug is called “NitroSynapsin” and the results published in the prestigious journal “Nature Communications” show its great efficiency in the brains of mice affected by this disease. In addition, the success of this medicine according to Lipton would also occur in patients with other types of autism, so that the range of people benefited would be very broad.
Now we have to keep fighting with more strength and enthusiasm to get a clinical trial and the day when this treatment can be provided to our children.
We are very happy that the research in which we have placed all our hope is giving result. THANK YOU TO ALL WHO ARE MAKING IT POSSIBLE!
In the following link you can find the article:
https://www.nature.com/articles/s41467-017-01563-8
